Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial.

Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER Trial. J Am Heart Assoc. 2018 12 18; 7(24):e009609.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Clinical Trials, Phase III as Topic
Female
Humans
Incidence
Intracranial Hemorrhages
Lactones
Male
Middle Aged
Multicenter Studies as Topic
Platelet Aggregation Inhibitors
Pyridines
Randomized Controlled Trials as Topic
Recurrence
Risk Assessment
Risk Factors
Secondary Prevention
Stroke
Treatment Outcome

authors with profiles

Robert Harrington